31 Dicembre 2023

MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia

Leukemia . – Vol. 37 (2023) . – p 1671–1685. – 61 bib ref

ultimo accesso 28/09/2023 https://doi.org/10.1038/s41375-023-01940-x

Nr. Estr. 9346

 

Abstract…